AstraZeneca: Deutsche Bank increases target price from 4100p to 4350p and reiterates its hold recommendation.
AVEVA: Societe Generale reduces target price from 2250p to 2000p, while keeping its buy recommendation.
Big Yellow Group: Citi raises target price from 470p to 540p and maintains its neutral rating.
B&M European Value Retail: Citi initiates with a target price of 310p and a buy recommendation.
Brammer: Investec cuts target price from 400p to 370p and retains a buy recommendation.
Cobham: Charles Stanley upgrades to hold.
Coca-Cola HBS: Societe Generale cuts target price from 1150p to 1100p and retains a sell recommendation. UBS reduces target price from 1450p to 1360p, keeping its neutral rating.
Experian: Canaccord raises target price from 858p to 928p and upgrades from sell to hold.
Filtronic: Panmure Gordon shifts target price from 20p to 23p and reiterates a hold recommendation.
Gem Diamonds: JP Morgan moves target price from 270p to 280p and keeps its overweight rating. Westhouse lowers target price from 235p to 210p and stays with its buy recommendation.
GlaxoSmithKline: Berenberg cuts target price from 1575p to 1540p and maintains a hold recommendation.
HSBC Holdings: Numis cuts target price from 725p to 700p and retains an add rating.
Infinis: Barclays initiates with a target price of 275p and an overweight rating.
Informa: Investec places its target price (prev.: 500p) under review, retaining its hold recommendation.
Inmarsat: Berenberg ups target price from 725p to 750p, retaining its hold recommendation.
Lookers: Panmure Gordon moves target price from 166p to 175p and leaves its buy recommendation unchanged.
Persimmon: Deutsche Bank moves target price from 1523p to 1533p and maintains a hold recommendation.
Petrofac: Deutsche Bank reduces target price from 1300p to 1200p, staying with its buy recommendation.
Playtech: JP Morgan reduces target price from 860p to 615p and downgrades to neutral.
Poundland Group: Citi initiates with a target price of 350p and a buy recommendation.
Promethean World: JP Morgan lowers target price from 33p to 24p, downgrading to underweight.
Randgold Resources: Westhouse reduces target price from 5000p to 4450p and leaves its add rating unaltered.
Royal Dutch Shell: Credit Suisse ups target price from 2625p to 2660p and maintains its outperform rating.
RSA Insurance: Deutsche Bank lowers target price from 505p to 500p and keeps a hold recommendation. Canaccord downgrades from hold to sell with a target price of 440p. UBS cuts target price from 427p to 418p and keeps a sell recommendation.
Schroders: Societe Generale reduces target price from 2620p to 2530p and stays with its hold recommendation. UBS raises target price from 2400p to 2800p and upgrades from neutral to buy.
Shire Pharmaceuticals: Credit Suisse reduces target price from 5400p to 4200p and reiterates a neutral rating.
SIG: Deutsche Bank cuts target price from 189p to 155p and retains a hold recommendation.
Spirax-Sarco Engineering: Investec places its target price (prev.: 2810p) under review, maintaining an add rating.
Sweett Group: N+1 Singer cuts target price from 45p to 34p and reiterates a buy recommendation.
Tate & Lyle: Deutsche Bank reduces target price from 900p to 750p, keeping a buy recommendation.
UBM: Citi reduces target price from 820p to 670p, while leaving its buy recommendation unchanged.
William Hill: Morgan Stanley ups target price from 425p to 460p, staying with an overweight rating.
3i Group: Citi ups target price from 430p to 455p and keeps a buy recommendation.